Phase II trial of sorafenib (bay 43-9006) in malignant mesothelioma: CALGB 30307
Publication
, Conference
Janne, PA; Wang, XF; Krug, LM; Hodgson, L; Vokes, EE; Kindler, HL
Published in: ANNALS OF ONCOLOGY
January 1, 2006
Duke Scholars
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
January 1, 2006
Volume
17
Start / End Page
216 / 217
Location
Istanbul, TURKEY
Publisher
OXFORD UNIV PRESS
Conference Name
31st Congress of the European-Society-for-Medical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Janne, P. A., Wang, X. F., Krug, L. M., Hodgson, L., Vokes, E. E., & Kindler, H. L. (2006). Phase II trial of sorafenib (bay 43-9006) in malignant mesothelioma: CALGB 30307. In ANNALS OF ONCOLOGY (Vol. 17, pp. 216–217). Istanbul, TURKEY: OXFORD UNIV PRESS.
Janne, Pasi A., Xiaofei F. Wang, Lee M. Krug, Lydia Hodgson, Everett E. Vokes, and Hedy L. Kindler. “Phase II trial of sorafenib (bay 43-9006) in malignant mesothelioma: CALGB 30307.” In ANNALS OF ONCOLOGY, 17:216–17. OXFORD UNIV PRESS, 2006.
Janne PA, Wang XF, Krug LM, Hodgson L, Vokes EE, Kindler HL. Phase II trial of sorafenib (bay 43-9006) in malignant mesothelioma: CALGB 30307. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2006. p. 216–7.
Janne, Pasi A., et al. “Phase II trial of sorafenib (bay 43-9006) in malignant mesothelioma: CALGB 30307.” ANNALS OF ONCOLOGY, vol. 17, OXFORD UNIV PRESS, 2006, pp. 216–17.
Janne PA, Wang XF, Krug LM, Hodgson L, Vokes EE, Kindler HL. Phase II trial of sorafenib (bay 43-9006) in malignant mesothelioma: CALGB 30307. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2006. p. 216–217.
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
January 1, 2006
Volume
17
Start / End Page
216 / 217
Location
Istanbul, TURKEY
Publisher
OXFORD UNIV PRESS
Conference Name
31st Congress of the European-Society-for-Medical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis